Blood Cancers | Tumor

FDA Grants Fast Track to UB-VV111 for B-Cell Blood Cancers

October 8th 2025, 3:04pm

Article

The FDA granted fast track status to UB-VV111 for patients with relapsed or refractory large B-cell lymphoma or chronic lymphocytic leukemia.

I No Longer Think About Cancer Every Day

September 30th 2025, 5:00pm

Article

From The Leukemia and Lymphoma Society to Blood Cancer United

September 24th 2025, 9:00pm

Video

CURE spoke with chief medical officer Gwen Nichols and partner Suleika Jaouad about the inclusive rebranding.

What Makes a Stem Cell Transplant Program Unique?

September 23rd 2025, 7:00pm

Article

Dr. Christina Cho explains that a strong transplant program provides advanced treatments along with a supportive team for patients with blood cancers.

The Leukemia & Lymphoma Society is Now Blood Cancer United

September 23rd 2025, 3:12pm

Article

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United.

Understanding Current Treatment for Myelofibrosis

September 23rd 2025, 1:00pm

Video

Dr. Prithviraj Bose discussed the current treatment landscape for myeloproliferative neoplasms, a group of rare blood cancers; he focused on myelofibrosis.

What Does a Blood Cancer Diagnosis Mean?

September 5th 2025, 8:00pm

Article

Your diagnosis of an early-stage blood cancer, such as a MPN or MDS, means that something has changed in the way your bone marrow produces blood cells.

Survivor Shares How Acupuncture and Nutrition Supported Treatment

August 13th 2025, 8:00pm

Video

Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and aided in remission.

New Guidelines Shift Donor Selection for Patients With Blood Cancer

August 11th 2025, 1:00pm

Video

Advancements in transplant medicine for blood cancers have prompted updates in how doctors choose donors for allogeneic hematopoietic cell transplants.

Revolutionizing CAR T-Cell Therapy to Improve Patient Access

August 3rd 2025, 6:00pm

Article

Dr. Olalekan O. Oluwole, discusses treating patients from underserved communities with CAR T-cell therapy, as well as highlighted the therapy's evolution.